Risperdal is Causing Gynecomastia in Young Boys
If you or a loved one have experienced side effects or complications after using Risperdal you may be eligible to file a claim against Johnson & Johnson. Houston attorney Mark Lanier and his firm are investigating claims that Johnson & Johnson and its Janssen unit hid serious risks when marketing the antipsychotic drug Risperdal (risperidone). Just simply call The Lanier Law Firm or fill out the form to see if you are eligible for a potential Risperdal lawsuit.
Risperdal is an atypical anti-psychotic medication approved to treat symptoms of schizophrenia, bipolar disorder, and autism. Unfortunately, thousands of doctors have prescribed Risperdal for unapproved uses, with serious consequences. The use of Risperdal has been linked to a condition called gynecomastia, or the enlargement of male breast tissue. This condition has been seen in young boys who have used Risperdal.
More than 420 lawsuits have been filed against Johnson & Johnson alleging serious personal injuries, and the U.S. Food & Drug Administration has issued several warnings related to the drug. Additionally, Johnson & Johnson has paid billions of dollars to resolve federal and state government allegations that the company illegally marketed several drugs, including Risperdal.
Risperdal has been linked to many severe side effects, including:
- Gynecomastia (growth of male breasts, which may be painful or tender)
- Galactorrhea (production of milk from breasts)
- Diabetes, high blood sugar (hyperglycemia)
- Bone loss (demineralization)
- Sexual dysfunction
- Pituitary tumors
- Tardive dyskinesia (involuntary movement disorder)
- Weight gain, which may be severe
- Neuroleptic Malignant Syndrome (NMS)
- Heart problems, heart attack, irregular heart rhythm
- Increased risk of death among elderly people with dementia
- And more
What Is Risperdal?
Risperidone is a potent antipsychotic drug that is mainly used to treat schizophrenia (including adolescent schizophrenia), schizoaffective disorder, the mixed and manic states associated with bipolar disorder, and irritability in people with autism. Risperdal is made and sold by the Johnson & Johnson subsidiary Ortho-McNeil-Janssen Pharmaceuticals Inc.
The use of Risperdal (risperidone) in young men has been linked to a condition called gynecomastia, or the enlargement of male breast tissue. Although gynecomastia is non-cancerous, the growth of male breasts can cause severe embarrassment and lasting psycho-social harm. Surgery may be required to correct the condition. In September 2012, Johnson & Johnson settled the first Risperdal gynecomastia lawsuit.
In males, Risperdal may cause enlargement of male breast tissue — a condition called gynecomastia. In a study published in 2006 in the Journal of Clinical Psychopharmacology, researchers warned: “Risperidone administered to adolescents at doses commonly used for the treatment of psychotic symptoms can strongly increase prolactin levels, with clinical consequences such as gynecomastia and/or galactorrhea. Given that the long-term effects of antipsychotic drug-induced hyperprolactinemia are not well documented, especially regarding osteopenia, infertility, growth, and pubertal delay, risperidone should be administered with caution to children and adolescents.”
If you or someone you know has been affected by the Risperdal and would like to know about how The Lanier Law Firm can represent you, please don’t hesitate to contact us to review your case and submit a claim. A case review costs nothing and has no obligation.